Meng, X., Yang, B., & Suen, W. (2017). Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome. Innate Immun.
Citação norma ChicagoMeng, Xiangxue, Bin Yang, and Wen-Chen Suen. "Prospects for Modulating the CD40/CD40L Pathway in the Therapy of the Hyper-IgM Syndrome." Innate Immun 2017.
Citação norma MLAMeng, Xiangxue, Bin Yang, and Wen-Chen Suen. "Prospects for Modulating the CD40/CD40L Pathway in the Therapy of the Hyper-IgM Syndrome." Innate Immun 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.